GemVax Raises 52.1 Billion KRW Through Capital Increase and Convertible Bonds
On December 24, GemVax, a KOSDAQ-listed company, announced that it has decided to raise approximately 17 billion KRW in operating funds, including research and development expenses, through a third-party allotment capital increase. The recipients are Gem&Company, the largest shareholder, and Kim Kiho, CEO of GemVax.
On the same day, GemVax also announced that it would raise 35.1 billion KRW in operating funds, including research and development expenses, through the issuance of convertible bonds (CB). The maturity date for the bonds is January 23, 2029.
Hot Picks Today
"I Ate It Often Because It Tasted Good"... This Eating Habit Linked to 40% Higher Odds of Asymptomatic Cerebrovascular Damage
- "Booked a Cheap Flight, Only to Get Blindsided"... Travelers' Complaints "Explode" Over Extra Fees
- "A College Degree Isn't Really Necessary"... Choi Taewon's Advice to Young People
- “Dad Just Gave It to Us as a Gift”... Scratched a Lottery Ticket at a Family Gathering and Hit a 1 Billion Won Jackpot
- "We've gone this far to save on lunch"... Where office workers are flocking instead of restaurants
As a result, GemVax will have raised a total of 52.1 billion KRW in funds.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
!["Please Take Them Off!" They Made It All the Way to the Bed... Then "80% of Fecal Bacteria" Struck [Deep Scroll]](https://cwcontent.asiae.co.kr/asiaresize/307/2026101610053063338_1792112730.png)
